BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with Peptides are unproven as health aids. FDA may unleash them anyway FDA moves toward easing restrictions on certain peptides BioPharma Dive Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law The Peptide Craze Ground Truths